Infliximab treatment for refractory kawasaki disease with coronary artery aneurysm - A 1-month-old girl

Circulation Journal

Volumn 72, Issue 5, 2008, Pages 850-852

  Oishi, Taku ^a   Fujieda, Mikiya ^b   Shiraishi, Taisuke ^a   Ono, Miki ^a   Inoue, Kazuo ^a   Takahashi, Akiyoshi ^a   Ogura, Hideo ^a   Wakiguchi, Hiroshi ^b  

^a National Hospital Organization Kochi National Hospital   (India)

^b KOCHI UNIVERSITY   (Japan)

Author keywords

Coronary aneurysm; Infant; Infliximab; Kawasaki disease

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ALBUMIN; C REACTIVE PROTEIN; CEFOTAXIME; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLIXIMAB; METHYLPREDNISOLONE; PREDNISOLONE; ULINASTATIN;

ALBUMIN BLOOD LEVEL; ARTICLE; CASE REPORT; CONJUNCTIVITIS; CORONARY ARTERY ANEURYSM; DISEASE CONTROL; DISEASE COURSE; DRUG DOSE INCREASE; DRUG PULSE THERAPY; ECHOCARDIOGRAPHY; ERYTHEMA; FEMALE; FEVER; HAND EDEMA; HUMAN; INFANT; LEUKOCYTE COUNT; LIVER DYSFUNCTION; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL COUNT; RASH; TREATMENT FAILURE;

ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CORONARY ANEURYSM; DRUG RESISTANCE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; INFANT, NEWBORN; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 44149127696     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.850     Document Type: Article

References (14)

1. Kawaski T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pedriatrics 1974; 54: 271-276.
2. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor, intedeukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 1990; 56: 29-36.
3. Leung DY, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS. Endothelial activation in the pathogenesis of Kawaski disease. Trans Assoc Am Physicians 1989; 102: 131-138.
4. Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 1996; 128: 146-149.
5. Raman V, Kim J, Sharkey A, Chatila T. Response of refractory Kawasaki disease to pulse steroid and cyclosporine A therapy. Pediatr Infect Dis J 2001; 20: 635-637.
6. Imagawa T, Mori M, Miyamae T, Ito S, Nakamura T, Yasui K, et al. Plasma exchange for refractory Kawasaki disease. Eur J Pediatr 2004; 163: 263-264.
7. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 1988; 48: 247-251.
8. Manicourt DH, Poilvace P, Van Egeren A, Devogelaer JP, Lenz ME, Thonar EJ. Synovial fluid levels of tumor necrosis factor α and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 2000; 43: 281-288.
9. Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS. Infliximab as a novel therapy for refractory Kawasaki Disease. J Rheumatol 2004; 31: 808-810.
10. Gerloni V, Pontikaki I, Gattinara M, Desiati F, Lupi E, Lurati A, et al. Efficacy of repeated intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: Results of an open-label prospective study. Arthritis Rheumatol 2005; 52: 548-553.
11. Katsicas MM, Russo RA. Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept. Clin Exp Rheumatol 2005; 23: 545-548.
12. Burrns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 2005; 146: 662-667.
13. Quasney MW, Bronstein DE, Cantor RM, Zhang Q, Stroupe C, Shike H, et al. Increased frequency of alleles associated with elevated tumor necrosis factor-α levels in children with Kawasaki disease. Pediatr Res 2001; 49: 686-690.
14. Kamizono S, Yamada A, Higuchi T, Kato H, Itoh K. Analysis of tumor necrosis factor-α production and polymorphisms of tumor necrosis factor-α gene in individuals with a history of Kawasaki disease. Pediatr Int 1999; 41: 341-345.